JPRN-UMIN000004415已完成未知
Optimal duration of proton pump inhibitor treatment for endoscopic submucosal dissection-induced ulcers - ESDPPI
Third Department of Internal Medicine, University of Toyama0 个研究点目标入组 50 人开始时间: 2010年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •serious complications including cardiac, haematological, renal and/or hepatic disease
研究者
相似试验
已完成
不适用
Is long-term use of proton pump inhibitors associated with vitamin B12 deficiency in elderly individuals?cobalamin deficiencylow vitamin B12 serum levels10047635NL-OMON29864eids Universitair Medisch Centrum220
已完成
不适用
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152
招募中
3 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis - a double-blind, placebo-controlled trialK74K65R18K72K72.79R17A49K76.7Fibrosis and cirrhosis of liverAscitesHepatic failure, not elsewhere classifiedHyperbilirubinaemia, with or without jaundice, not elsewhere classifiedBacterial infection of unspecified sitePeritonitisHepatorenal syndromeDRKS00021290niversitätsklinikum Hamburg-Eppendorf476
招募中
4 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)2023-509863-26-00University Medical Center Hamburg-Eppendorf476
招募中
1 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)iver cirrhosisCTIS2023-509863-26-00niversity Medical Center Hamburg-Eppendorf476